FDA Grants Accurexa Pre-IND Meeting for its ACX-31 Program in the Treatment of Brain Cancer
This is a new platform for delivering treatments into the brain tumor directly. Higher dosages can be achieved in the tumor, with less or no exposure to the rest of the body. Work in mice showed that Temozolomide and BCNU given directly into the tumor work a lot better than the standard ways of giving it. Hopefully this will translate into patients quickly.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://finance.yahoo.com/news/fda-grants-accurexa-pre-ind-120000970.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines